HRTX 8-K 2026-09-29

HERON THERAPEUTICS, INC. /DE/ (HRTX) 8-K dated 2026-09-29 — accession 0001193125-26-407728. This URL is the filing, not the HRTX hub.

HERON THERAPEUTICS, INC. /DE/ (HRTX) is a biotechnology company listed on US.

HERON THERAPEUTICS, INC. /DE/ filed a 8-K on 2026-09-29. Accession 0001193125-26-407728.

Cached items: 1.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported HRTX revenue for 2025-12-31 was $154.9M. Net income was -$20.2M. Revenue was up 7.4% from 2024-12-31 to 2025-12-31. HRTX currently screens at market cap $332.6M.

Not investment advice. The HRTX SEC hub lists recent forms. The stock page is the research view.